biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > sent a pm to kbc this morning - no response

<< Previous

Bullboard Posts

Next >>

Comment by KayakerBCon Dec 21, 2022 2:44pm

135 Views

Post# 35185371

RE:sent a pm to kbc this morning - no response

fuzzyjr, had ya on ignore but ya snuck past lol. You're too much of a POOF Fanboy sometimes. I can only take limited doses. If offends my moral and ethical sensitivities, er sensibilities, er whatever.

Deal? Future? Alternatives? I sold some and will wait it out with the rest. If it continues to slide into the abyss from these lofty 5¢ levels, I'll keep the tax loss option in mind. Otherwise, I have nothing to add to JD..., er BS's fine analysis.

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading